Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.34 USD | -0.32% | +2.13% | -10.08% |
May. 28 | Bausch + Lomb's New Intraocular Lens Approved by Health Canada | MT |
May. 28 | Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.08% | 5.39B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- BLCO Stock
- News Bausch + Lomb Corporation
- Barclays Adjusts Price Target on Bausch + Lomb to $19 From $18, Maintains Equalweight Rating